Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 191

Sort by

Sort Order Select

Journal Articles

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Blood (2020) 135 (3): 181–190.

https://doi.org/10.1182/blood.2019000560

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

Luis Colomo, Ivonne Vazquez, Natalia Papaleo, Marta Salido, Anna Puiggros, Blanca Espinet, Maria Rodriguez-Rivera, Ramon Diez-Feijoo, Blanca Sanchez-Gonzalez, Antonio Salar, Ana Ferrer, Leonor Arenillas, Marcio Andrade Campos, MD PhD, Xavier Calvo

Blood (2019) 134 (Supplement_1): 2899.

https://doi.org/10.1182/blood-2019-125717

Published: 2019

Journal Articles

Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Bernd Metzner, MD PhD, Jochen Casper, MD PhD, Koehne Claus-Henning, MD PhD, Andrea Renzelmann, MD, Thomas H. Mueller, MD PhD, Eduard K. Petershofen, MD PhD, Bernd Rosien, MD, Ruth Thole, MD, Andreas Voss, MD, Martin H. Dreyling, MD PhD, Eva Hoster, PhD, Wolfram Klapper, Christiane Pott, MD PhD

Blood (2019) 134 (Supplement_1): 2819.

https://doi.org/10.1182/blood-2019-122353

Published: 2019

Journal Articles

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MD PhD, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Wan X. Hong, MD, Rachel Greenstein, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 2825.

https://doi.org/10.1182/blood-2019-129661

Published: 2019

Journal Articles

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Keenan T. Hartert, PhD, Kerstin Wenzl, PhD, Jordan Krull, Michelle Manske, MS, BS, Vivekananda Sarangi, Melissa C Larson, Theodora Anagnostou, MD, Ellen D. McPhail, MD, Brian K. Link, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Dragan Jevremovic, MD PhD, Anne J Novak, PhD

Blood (2019) 134 (Supplement_1): 2764.

https://doi.org/10.1182/blood-2019-128803

Published: 2019

Journal Articles

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Victor Bobée, PharmD, Fanny Drieux, MD, Vinciane Marchand, Vincent Sater, Liana Veresezan, MD, Jean-Michel Picquenot, MD, Pierre-Julien Viailly, Marie-delphine Lanic, Mathieu Viennot, Elodie Bohers, PhD, Lucie Oberic, MD, Christiane Copie-Bergman, MD PhD, Thierry Jo Molina, MD PhD, Philippe Gaulard, MD PhD, Corinne Haioun, MD PhD, Gilles A. Salles, MD PhD, Herve Tilly, MD PhD, Fabrice Jardin, Philippe Ruminy, PhD

Blood (2019) 134 (Supplement_1): 1476.

https://doi.org/10.1182/blood-2019-122405

Published: 2019

Journal Articles

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Tanaya Shree, MD PhD, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 1479.

https://doi.org/10.1182/blood-2019-131684

Published: 2019

Journal Articles

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Christian Schmidt, MD, Anna-Katharina Zoellner, Vindi Jurinovic, Martin Sökler, MD, Roswitha Forstpointner, Sascha Haubner, MD, Christian Buske, MD, Andreas Viardot, MD, Ulrich Keller, Christiane Pott, Ullrich Graeven, MD, Reinhard Marks, Mathias Hänel, MD, Ruediger Liersch, Jan Dürig, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann

Blood (2018) 132 (Supplement 1): 448.

https://doi.org/10.1182/blood-2018-99-111692

Published: 2018

Journal Articles

Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial

Meirav Kedmi, MD, Elena Ribakovsy, MD, Ohad Benjamini, MD, Ginette Schiby, MD, Iris Barshack, MD, Stephen P Raskin, MD, Yael Eshet, MD, Ramit Mehr, PhD, Guy Bitansky, Arnon Nagler, MD, Abraham Avigdor, MD

Blood (2018) 132 (Supplement 1): 4186.

https://doi.org/10.1182/blood-2018-99-111658

Published: 2018

Journal Articles

Follicular Lymphoma Grade 3A Exhibits Pathological and Cytogenetic Diversity, but Similar Prognosis Compared to FL Grade 1-2: Pooled Analysis of 1757 Follicular Lymphomas from the PRIMA and Relevance Trials

Camille Laurent, MD PhD, Danielle Canioni, MD, Bettina Fabiani, MD, Véronique Meignin, Catherine Chassagne-Clément, MD, Peggy Dartigues-Cuillères, MD, Christiane Copie, MDPhD, Guillaume Cartron, Franck Morschhauser, MD, Gilles Salles, MD PhD, Luc Xerri, MD PhD

Blood (2018) 132 (Supplement 1): 778.

https://doi.org/10.1182/blood-2018-99-115831

Published: 2018

Journal Articles

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Tanaya Shree, MD PhD BA, Anuja Sathe, PhD, Debra K. Czerwinski, BA, Steven R. Long, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2018-99-119925

Published: 2018

Journal Articles

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Hidong Kim, MD, Laura Harper, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Patrick Johnston, Thomas E. Witzig, MD, Cristine Allmer, BS, Matthew J. Maurer, MS, James R. Cerhan, MD PhD, Jason Young, MD, Gita Thanarajasingam, MD

Blood (2018) 132 (Supplement 1): 5401.

https://doi.org/10.1182/blood-2018-99-117711

Published: 2018

Journal Articles

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Erden Atilla, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Onder Arslan, MD, Taner Demirer, MD, Meral Beksac, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2017) 130 (Supplement 1): 5528.

https://doi.org/10.1182/blood.V130.Suppl_1.5528.5528

Published: 2017

Journal Articles

Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study

Suzanne Duhamel, MD, Dania Mohty, MD PhD, Julien Magne, PhD, David Lavergne, PhD, Dominique Bordessoule, MD, Victor Aboyans, MD PhD, Arnaud Jaccard

Blood (2017) 130 (Supplement 1): 5577.

https://doi.org/10.1182/blood.V130.Suppl_1.5577.5577

Published: 2017

Journal Articles

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Darrko Antic, Mihaljevic Biljana, Natasa Milic, Bruce D. Cheson, MD, Mayur Narkhede, MD, Irina Panovska, Sanja Trajkova, Marija Popova, Pilar Llamas, MDPhD, Arantxa Garcías Raso, Aurelien Delluc, MD PhD, Jean-Christophe Ianotto, MD, Grigorios T. Gerotziafas, MD PhD, Jawed Fareed, PhD

Blood (2017) 130 (Supplement 1): 558.

https://doi.org/10.1182/blood.V130.Suppl_1.558.558

Published: 2017

Journal Articles

Functional Implication of p53-Mediated DNA Damage Response on the B-Cell Lymphoma Microenvironment Interaction in Chemoimmunotherapy

Daniela Vorholt, PhD, Nadine Nickel, PhD, Christian Reinhardt, MD, Michael J. Hallek, MD, Christian Pallasch, MD

Blood (2017) 130 (Supplement 1): 3841.

https://doi.org/10.1182/blood.V130.Suppl_1.3841.3841

Published: 2017

Journal Articles

Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Bernd Metzner, MD, PhD, Bernd Rosien, MD, Jochen Casper, MD, PhD, Claus-Henning Köhne, MD, PhD, Doris M. Kraemer, MD, PhD, Thomas H. Mueller, MD, PhD, Andrea Renzelmann, MD, Ruth Thole, MD, Christiane Pott, MD, PhD

Blood (2017) 130 (Supplement 1): 4539.

https://doi.org/10.1182/blood.V130.Suppl_1.4539.4539

Published: 2017

Journal Articles

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Simon J Bulley, Isabel C Lentell, Brendan O'Sullivan, Annabel M Follows, Shalal Sadullah, Mamatha Karanth, MD, Sandra Young Min, James Russell, MA,MBBChir,MRCP, Benjamin J Uttenthal, MD PhD, George A Follows, MD PhD

Blood (2017) 130 (Supplement 1): 4157.

https://doi.org/10.1182/blood.V130.Suppl_1.4157.4157

Published: 2017

Journal Articles

Long-Term Follow-up of Patients with Indolent Lymphoma after First Line Therapy with Rituximab As Single Agent or in Combination with Interferon-α2a

Sandra Lockmer, Bjorn Ostenstad, Hans Hagberg, Harald Holte, Björn Engelbrekt Wahlin, Chloe Beate Steen, Peter de Nully Brown, MD PhD, Eva Kimby

Blood (2017) 130 (Supplement 1): 2768.

https://doi.org/10.1182/blood.V130.Suppl_1.2768.2768

Published: 2017

Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar

Blood (2017) 130 (Supplement 1): 2786.

https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786

Published: 2017

NARROW

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas

Combining Gene Expression Profiling and Artificial Intelligence to Diagnose B-Cell Non-Hodgkin Lymphoma

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial

Follicular Lymphoma Grade 3A Exhibits Pathological and Cytogenetic Diversity, but Similar Prognosis Compared to FL Grade 1-2: Pooled Analysis of 1757 Follicular Lymphomas from the PRIMA and Relevance Trials

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Functional Implication of p53-Mediated DNA Damage Response on the B-Cell Lymphoma Microenvironment Interaction in Chemoimmunotherapy

Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Long-Term Follow-up of Patients with Indolent Lymphoma after First Line Therapy with Rituximab As Single Agent or in Combination with Interferon-α2a

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only